Mantra Bio
San Francisco
About Mantra Bio
Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: mantrabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mantra-bio-64888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.